Measures taken by Telangana to recall a batch of Thyronorm tablets mislabelled

The Drug Control Administration of Telangana is making sure that a mislabelled batch of Thyronorm tablets is taken off the market. Abbott voluntarily recalled the batch due to a labelling error which said that the tablets contained 25 micrograms instead of the actual 88 micrograms. The Drug Control Administration has issued a circular to drug inspectors in Telangana to recall the mislabelled batch and make sure it is not being sold. The circular also asks the drug inspectors to submit a compliance report to the Joint Director. Abbott said that there were no quality issues with the product and that no patients were impacted. Patients who have recently purchased Thyronorm with batch No. AEJ0713 have been requested to return the bottle or notify Abbott. The company is working with distributors and partners to facilitate the recall.